Discounted Cash Flow (DCF) Analysis Levered
Second Sight Medical Products Inc (EYESW)
$0.2198
+0.02 (+9.90%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
| Revenue | 7.96 | 6.90 | 3.38 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (%) | ||||||||||
| Operating Cash Flow | -23.95 | -29.81 | -27.63 | -16.82 | -0.01 | -0.35 | -0.14 | -0.06 | -0.02 | -0.01 |
| Operating Cash Flow (%) | ||||||||||
| Capital Expenditure | -0.27 | -0.16 | -0.49 | -0.33 | -0 | -0.01 | -0 | -0 | -0 | -0 |
| Capital Expenditure (%) | ||||||||||
| Free Cash Flow | -24.21 | -29.97 | -28.12 | -17.15 | -0.01 | -0.36 | -0.15 | -0.06 | -0.02 | -0.01 |
Weighted Average Cost Of Capital
| Share price | $ 0.2,198 |
|---|---|
| Beta | 2.117 |
| Diluted Shares Outstanding | 32.82 |
| Cost of Debt | |
| Tax Rate | 0.00 |
| After-tax Cost of Debt | -% |
| Risk-Free Rate | |
| Market Risk Premium | |
| Cost of Equity | 13.683 |
| Total Debt | 0.24 |
| Total Equity | 7.21 |
| Total Capital | 7.45 |
| Debt Weighting | 3.18 |
| Equity Weighting | 96.82 |
| Wacc |
Build Up Free Cash Flow
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
| Revenue | 7.96 | 6.90 | 3.38 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -23.95 | -29.81 | -27.63 | -16.82 | -0.01 | -0.35 | -0.14 | -0.06 | -0.02 | -0.01 |
| Capital Expenditure | -0.27 | -0.16 | -0.49 | -0.33 | -0 | -0.01 | -0 | -0 | -0 | -0 |
| Free Cash Flow | -24.21 | -29.97 | -28.12 | -17.15 | -0.01 | -0.36 | -0.15 | -0.06 | -0.02 | -0.01 |
| WACC | ||||||||||
| PV LFCF | - | - | - | - | - | |||||
| SUM PV LFCF | - |
Terminal Value
| Growth in perpetuity method: | |
|---|---|
| Long-term growth rate | |
| WACC (%) | - |
| Free cash flow (t + 1) | -0.01 |
| Terminal Value | - |
| Present Value of Terminal Value | - |
Intrinsic Value
| Enterprise Value | - |
|---|---|
| Net Debt | -69.36 |
| Equity Value | - |
| Shares Outstanding | 32.82 |
| Equity Value Per Share | - |